在质母细胞瘤免疫治疗中使用PD-1抑制剂的应用
Ming-Zhen Dong1, Ming Cui2, Lin-Zhuo Qu1
1Neurology Department, Yanbian University Hospital, Yanji, China.
概括
质母细胞瘤免疫疗法,特别是PD-1抑制剂,单独表现出适度的结果,但与其他治疗相结合时有效性得到改善. 本综述总结了批准的PD-1抑制剂用于质母细胞瘤,探索组合疗法和未来的研究.
科学领域:
- 神经瘤学神经瘤学
- 免疫疗法是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
- 目前的治疗包括手术,化疗和放射治疗,经常面临药物耐药性.
- 免疫疗法为各种固体瘤提供了一种新的治疗策略.
研究的目的:
- 审查已批准的PD-1抑制剂用于质母细胞瘤 (GBM).
- 总结PD-1抑制剂在GBM单一治疗和联合治疗中的疗效.
- 讨论针对GBM的PD-1抑制剂治疗的前景和最近的进展.
主要方法:
- 在GBM中对PD-1抑制剂的临床研究的文献综述.
- 对单疗法和组合疗法方法的分析.
- 已批准的PD-1抑制剂及其临床结果的摘要.
主要成果:
- 单一治疗PD-1抑制剂在GBM中显示出有限的临床益处.
- 组合疗法 (含化疗,放射治疗,瘤治疗病毒,疫苗,其他检查点抑制剂,CAR-T) 显示出更高的疗效和安全性.
- 几种PD-1抑制剂已被批准用于GBM治疗.
结论:
- 组合免疫疗法,特别是PD-1抑制剂,是对GBM的一个有希望的方法.
- 需要进一步的研究来优化组合策略和克服治疗耐药性.
- PD-1 抑制剂在不断发展的GBM治疗领域中代表着重大进展.
更多相关视频
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.2K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.7K
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
PD Controller: Design
669
In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
669
Time-Domain Interpretation of PD Control
408
Proportional-Derivative (PD) control is a widely used control method in various engineering systems to enhance stability and performance. In a system with only proportional control, common issues include high maximum overshoot and oscillation, observed in both the error signal and its rate of change. This behavior can be divided into three distinct phases: initial overshoot, subsequent undershoot, and gradual stabilization.
Consider the example of control of motor torque. Initially, a positive...
Consider the example of control of motor torque. Initially, a positive...
408
Frequency-Domain Interpretation of PD Control
394
Proportional-Derivative (PD) controllers are widely used in fan control systems to improve stability and performance. A fan control system can be effectively represented using a Bode plot to illustrate the impact of a PD controller through its transfer function. The Bode plot visually conveys how PD control modifies the fan's response across various frequencies, providing a frequency domain interpretation of the controller's behavior.
The proportional control gain, combined with the...
The proportional control gain, combined with the...
394
Dipeptidyl Peptidase 4 Inhibitors
718
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
718
